 Structural Heart Devices Structural heart disease are congenital diseases, which means they are present from birth and this leads to defects in the walls of chambers or valves of the heart. Some structural heart disease develop later on in life and the chances of having such diseases increases in individuals with atherosclerosis, or high blood pressure, or individuals who have suffered from a heart attack previously, or cardiomyopathy, rheumatic fever or endocarditis or some other infection. Most common structural heart disease are aortic valve stenosis, left ventricular hypertrophy, atrial septal defect, marfan syndrome, mitral valve regurgitation, cardiomyopathy and myocarditis.
Structural heart devices are used for repairing or replacing structural heart diseases, they are used for treating heart related disorders. Heart valve balloons occluders, annuloplasty rings are type of structural heart diseases. Such devices help in tightening or reshaping the heart in case there is damaged valve or the heart is enlarged. According to Coherent Market Insights the Structural Heart Devices Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Structural heart occluders can be helpful in treating heart openings, defects and appendages. The occluder is attached to the catheter and is inserted inside a vein, later on the device is pushed out from the catheter, so that each side of the defect is covered, thus closing the defect. Later on the heart tissues grow on the implant with time. Around 71,000 children in the United States of America and European Union are born with structural heart defects every year. Nearly 1% of newborn babies, almost 40,000 babies suffer from congenital heart defects in the U.S. These newborns will need to under surgeries in the first year after birth for leading a healthy life. Growing awareness about heart diseases and favorable reimbursement policies are driving the growth of the global structural hearts devices market. Furthermore, the prevalence of structural heart disease is on the rise across the globe, and the need for these devices is likely to continue. Some of the common structural heart diseases include atrial septal defect, aortic valve stenosis, and patent foramen oval. There has been an emergence of new products and technological developments in the field in the past few years. The technology behind structural heart devices has evolved significantly over the last few decades. In order to ensure optimal safety and effectiveness, structural heart devices must meet specific requirements. These include accurate imaging of target structures and lesions. The resulting images enable interventionalists to insert the device precisely and safely. However, these technological advances have given rise to various risks and complications. Increasing adoption of transcatheter aortic valve replacement is based on solid clinical evidence, and myriad devices are expected to meet mitral valve treatment needs in the future. Similarly, interventional imaging techniques will pave the way for more complex structural heart procedures. While the technology has improved, the process of establishing a high volume structural heart program will remain a challenge. This is a multidisciplinary endeavor requiring specialists with advanced training and specialized training. There is a need for innovative devices to help in treating structural heart disease, as there are about 60 million Americans with this condition. The device has been used to treat both congenital and acquired heart disease. These medical devices are used to repair aortic stenosis.
0 Comments
Leave a Reply. |
RSS Feed
